DGAP-News: Moderna, Inc.: Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
DGAP-News: Moderna, Inc.
/ Key word(s): Miscellaneous
Moderna, Inc.: Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
17.02.2022 / 06:20
The issuer is solely responsible for the content of this announcement.